Insider: BENNETT C FRANK EVP, Chief Scientific Officer - IONIS PHARMACEUTICALS INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 82,679 | 0 | 82,679 |
| Value | $5,302,617.67 | $0.00 | $5,302,617.67 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 09/05/2025 | DDS | 6,000 | Direct | COM | $59.60 | $357,580.80 | 82,679 |
| 09/03/2025 | DDS | 33,909 | Direct | COM | $60.62 | $2,055,563.58 | 101,570 |
| 09/02/2025 | DDS | 5,000 | Direct | COM | $49.14 | $245,700.00 | 88,679 |
| 08/18/2025 | DDS | 10,000 | Direct | COM | $43.98 | $439,776.00 | 93,466 |
| 01/31/2025 | DDS | 1,327 | Direct | COM | $32.46 | $43,079.20 | 93,146 |
| 01/16/2025 | DDS | 6,752 | Direct | COM | $32.90 | $222,113.79 | 90,866 |
| 02/02/2024 | DDS | 1,853 | Direct | COM | $49.52 | $91,752.41 | 79,079 |
| 01/17/2024 | DDS | 6,745 | Direct | COM | $50.42 | $340,062.67 | 77,323 |
| 12/21/2023 | DDS | 16,113 | Direct | COM | $49.29 | $794,211.38 | 65,754 |
| 12/20/2023 | DDS | 6,500 | Direct | COM | $49.64 | $322,643.10 | 65,754 |
| 12/14/2023 | DDS | 14,002 | Direct | COM | $49.21 | $689,084.63 | 65,754 |
| 12/14/2023 | DDS | 8,610 | Direct | COM | $50.19 | $432,110.07 | 65,754 |
| 09/28/2023 | DDS | 4,460 | Direct | COM | $46.50 | $207,390.00 | 65,754 |
| 02/06/2023 | DDS | 1,813 | Direct | COM | $40.57 | $73,560.30 | 69,651 |
| 01/18/2023 | DDS | 6,978 | Direct | COM | $38.89 | $271,356.28 | 67,855 |
| 11/03/2020 | DDS | 15,000 | Direct | COM | $46.77 | $701,599.50 | 32,476 |
| 06/25/2020 | DDS | 15,000 | Direct | COM | $59.77 | $896,505.00 | 32,364 |
| 06/25/2020 | DDS | 15,000 | Direct | COM | $59.77 | $896,505.00 | 32,364 |
| 02/01/2019 | DDS | 9,013 | Direct | COM | $58.29 | $525,367.77 | 24,528 |
| 11/01/2018 | DDS | 12,500 | Direct | COM | $49.54 | $619,245.00 | 19,396 |
| 08/08/2018 | DDS | 13 | Direct | COM | $45.00 | $585.00 | 19,396 |
| 08/08/2018 | DDS | 12,487 | Direct | COM | $45.00 | $561,915.00 | 19,396 |
| 05/11/2018 | DDS | 12,500 | Direct | COM | $45.00 | $562,500.00 | 19,114 |
| 01/16/2018 | DDS | 2,696 | Direct | COM | $51.76 | $139,544.96 | 19,114 |
| 10/18/2017 | DDS | 12,250 | Direct | COM | $65.00 | $796,250.00 | 15,041 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research